Q
Quoin Pharmaceuticals, Ltd. (QNRX)
NCM – Real vaqt narxi. Valyuta: USD
4.45
+0.25 (5.95%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
4.34
-0.11 (-2.42%)
Bozordan keyin: Jun 26, 2026, 7:58 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
4.45
+0.25 (5.95%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
4.34
-0.11 (-2.42%)
Bozordan keyin: Jun 26, 2026, 7:58 PM EDT
Quoin Pharmaceuticals, Ltd., kechki bosqichdagi ixtisoslashgan farmatsevtika kompaniyasi bo'lib, Qo'shma Shtatlarda kam uchraydigan va yetim kasalliklar uchun terapevtik mahsulotlarni ishlab chiqish va tijoratlashtirishga qaratilgan. Kompaniyaning asosiy mahsuloti QRX003, mahalliy qo'llaniladigan losyon bo'lib, u Netherton sindromi (NS)ni davolash uchun 2-bosqichda; peeling skin sindromini davolash uchun 1-bosqichda; va SAM sindromi va ichthiyosisni davolash uchun preklinik bosqichda turibdi. Kompaniya, shuningdek, preklinik bosqichda bo'lgan sklerodermiyani davolash uchun QRX008ni ishlab chiqadi; va mikrotsistik limfatik malformatsiyalar, venoz malformatsiyalar, angiofibroma va boshqa kasalliklarni davolash uchun QRX009ni ishlab chiqadi. Kompaniya Queensland texnologiya universiteti bilan tadqiqot shartnomasiga ega. Quoin Pharmaceuticals, Ltd. 2018 yilda tashkil etilgan va Ashburn, Virdjiniyada joylashgan. Quoin Pharmaceuticals, Ltd. Skinvisible, Inc. sho'ba korxonasidir.
| Ism | Lavozim |
|---|---|
| Dr. Michael Myers Ph.D. | Co-Founder, CEO & Chairman |
| Ms. Denise Carter | Co-Founder, COO & Director |
| Ms. Sally Lawlor | Chief Financial Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-06-23 | 8-K | tm2618505d1_8k.htm |
| 2026-06-04 | 8-K | tm2616916d1_8k.htm |
| 2026-05-07 | 8-K | tm2613938d1_8k.htm |
| 2026-05-07 | 10-Q | qnrx-20260331x10q.htm |
| 2026-03-26 | 10-K | qnrx-20251231x10k.htm |
| 2026-03-11 | 8-K | tm268576d1_8k.htm |
| 2026-01-20 | 8-K | tm263667d1_8k.htm |
| 2025-12-02 | CORRESP | filename1.htm |
| 2025-11-17 | 8-K | tm2531454d1_8k.htm |
| 2025-11-12 | 8-K | tm2530990d1_8k.htm |